April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
April 11, 2022
The University of Cincinnati's Stacie Demel, DO, PhD, was featured in a Reuters Health article commenting on a new AHA/ASA statement on treatment for stroke patients with disability or dementia.
April 8, 2022
Southwest Ohio Parent featured the University of Cincinnati's Louito Edje in an article about seven health screenings every woman should have.
April 6, 2022
The University of Cincinnati's Dr. Maria Espinola was featured in a New York Times article about the role of artificial intelligence in identifying mental disorders through the sound of a patient's voice.
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
April 5, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is researching how different rates of cerebral small vessel disease and genetic differences contribute to higher rates of Alzheimer's disease and related dementias in non-Hispanic Black populations compared to non-Hispanic white patients.
April 1, 2022
Medscape featured the University of Cincinnati's Dr. Donald Gilbert in an article about a new drug that has been shown to be effective in reducing tics in Tourette syndrome patients while causing less side effects.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
March 28, 2022
The University of Cincinnati's Daniel Woo and colleagues recently published a paper in JAMA revealing new insights on how different risk factors following intracerebral hemorrhages can affect patient outcomes.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.